Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

EP Biocomposites

₹131 -3.9 | 2.9%

Market Cap ₹22 Cr.

Stock P/E

P/B 2.6

Current Price ₹131

Book Value ₹ 50

Face Value 10

52W High ₹254

Dividend Yield 0%

52W Low ₹ 122

EP Biocomposites Research see more...

Overview Inc. Year: 2020Industry: Plastic Products

EP Biocomposites Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

EP Biocomposites Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

EP Biocomposites Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 1 3 8 7
Other Income 0 0 0 0
Total Income 1 3 8 7
Total Expenditure 1 2 7 6
Operating Profit 0 0 1 1
Interest 0 0 0 0
Depreciation 0 0 0 0
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 0 0 1 1
Provision for Tax 0 0 0 0
Profit After Tax 0 0 1 1
Adjustments 0 0 0 0
Profit After Adjustments 0 0 1 1
Adjusted Earnings Per Share 0.8 9.5 6.9 3.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -13% 91% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -32% NA% NA% NA%
ROE Average 11% 84% 91% 91%
ROCE Average 13% 93% 104% 104%

EP Biocomposites Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 0 0 2 8
Minority's Interest 0 0 0 0
Borrowings 0 0 2 1
Other Non-Current Liabilities 0 0 0 0
Total Current Liabilities 1 1 5 2
Total Liabilities 1 1 9 12
Fixed Assets 0 0 0 0
Other Non-Current Assets 0 0 0 2
Total Current Assets 1 1 9 9
Total Assets 1 1 9 12

EP Biocomposites Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0
Cash Flow from Operating Activities 0 0 -4 -1
Cash Flow from Investing Activities 0 0 -0 0
Cash Flow from Financing Activities -0 -0 5 3
Net Cash Inflow / Outflow 0 0 0 2
Closing Cash & Cash Equivalent 0 0 0 2

EP Biocomposites Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.84 9.55 6.87 3.43
CEPS(Rs) 0.84 9.55 7.44 4.02
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 0.76 10.31 16.97 50.04
Core EBITDA Margin(%) 7.6 15.65 17.48 13.71
EBIT Margin(%) 7.64 15.79 16.85 14.64
Pre Tax Margin(%) 7.59 15.75 14.47 11.42
PAT Margin (%) 5.54 12.14 10.04 8.08
Cash Profit Margin (%) 5.54 12.15 10.86 9.48
ROA(%) 5.71 38.18 15.27 5.49
ROE(%) 110.53 172.53 67.88 11.07
ROCE(%) 140 222.95 41.82 13.21
Receivable days 193.97 58.75 175.34 331.63
Inventory Days 71.45 34.74 36.97 56.27
Payable days 406.83 142.02 104.49 150.42
PER(x) 0 0 0 58.81
Price/Book(x) 0 0 0 4.03
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) -0.11 -0.03 0.64 4.62
EV/Core EBITDA(x) -1.46 -0.21 3.6 28.83
Net Sales Growth(%) 0 418.92 173.39 -11.52
EBIT Growth(%) 0 972.35 191.88 -23.15
PAT Growth(%) 0 1036.51 126.09 -28.82
EPS Growth(%) 0 1036.51 -28 -50.16
Debt/Equity(x) 0.09 0 2.06 0.15
Current Ratio(x) 1.06 1.39 1.73 4.45
Quick Ratio(x) 0.84 0.91 1.49 3.96
Interest Cover(x) 144.67 387.83 7.06 4.54
Total Debt/Mcap(x) 0 0 0 0.04

EP Biocomposites Shareholding Pattern

# Sep 2022 Mar 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 69.31 70.08 70.08 70.08 70.08
FII 1.19 2.2 2.2 2.2 2.2
DII 0 0 0 0 0
Public 29.5 27.72 27.72 27.72 27.72
Others 0 0 0 0 0
Total 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 84%
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Debtor days have increased from 104.49 to 150.42days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

EP Biocomposites News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....